Trials / Recruiting
RecruitingNCT07045688
Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection
Efficacy of Vonoprazan Based Dual and Triple Therapy for Naive Patient With Helicobacter Pylori Infection
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection | we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient. |
| DRUG | Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection | we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient. |
| DRUG | Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection | we assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient. |
Timeline
- Start date
- 2025-05-13
- Primary completion
- 2025-11-25
- Completion
- 2025-11-25
- First posted
- 2025-07-01
- Last updated
- 2025-07-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07045688. Inclusion in this directory is not an endorsement.